Cyclin D1 抗体
(Cyclin D1 (CCND1))
The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| Cyclin D1 抗体 (AA 61-110) | 小鼠 | 兔 Polyclonal |
|
|
|
| Cyclin D1 抗体 (AA 68-97) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| Cyclin D1 抗体 (AA 1-295) | 人, 小鼠 | 小鼠 Monoclonal |
|
|
|
| Cyclin D1 抗体 (AA 167-295) | 人 | 小鼠 Monoclonal |
|
|
|
| Cyclin D1 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant Cyclin D1 抗体 | 人 | 兔 Monoclonal |
|
|
|
| Cyclin D1 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| Cyclin D1 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| Cyclin D1 抗体 (AA 68-97) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| Cyclin D1 抗体 (C-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| Cyclin D1 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| Cyclin D1 抗体 (AA 250-300) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| Cyclin D1 抗体 (AA 1-295) | 大鼠 | 兔 Polyclonal |
|
|
|
| Cyclin D1 抗体 (AA 1-295) | 人 | 小鼠 Polyclonal |
|
|
|
| Cyclin D1 抗体 (AA 1-295) | 人 | 小鼠 Polyclonal |
|
|
|
| Recombinant Cyclin D1 抗体 (C-Term) | 人 | 兔 Monoclonal |
|
|
|
| Cyclin D1 抗体 (AA 115-270) | 人 | 小鼠 Monoclonal |
|
|
|
| Cyclin D1 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| Cyclin D1 抗体 (AA 147-175) | 人 | 兔 Polyclonal |
|
|
|
| Cyclin D1 抗体 (AA 203-238) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IF (cc) (Immunofluorescence (Cultured Cells): 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
15 references - 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 61-110
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB8066
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 68-97
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1F7F5
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 1-295
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 3B6G3
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 167-295
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- 质量等级
- KD Validated
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 23GB735
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- SDS (SDS-PAGE: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- DCS-6
- 标记
- unconjugated
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 68-97
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- PAr (Protein Array: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CCND1-2593
- 标记
- unconjugated
- 抗体亚型
- IgG1, kappa
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 250-300
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-295
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-295
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- PLA (Proximity Ligation Assay: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-295
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- SDS (SDS-PAGE: 有验证图片)
- PAr (Protein Array: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CCND1-3548
- 标记
- unconjugated
- 抗体亚型
- IgG2b, kappa
- 抗原表位
- AA 115-270
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB42158
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 267-294, C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB14995
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 147-175
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB16619
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 203-238
Latest Publications for our Cyclin D1 抗体
: "LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer." in: Cancer medicine, Vol. 9, Issue 2, pp. 724-736, (2021) (PubMed).
: "The Toll-like receptor ligand, CpG oligodeoxynucleotides, regulate proliferation and osteogenic differentiation of osteoblast." in: Journal of orthopaedic surgery and research, Vol. 15, Issue 1, pp. 327, (2021) (PubMed).
: "ASIC1a Inhibitor mambalgin-2 Suppresses the Growth of Leukemia Cells by Cell Cycle Arrest." in: Acta naturae, Vol. 12, Issue 2, pp. 101-116, (2020) (PubMed).
: "Microvesicles from human adipose stem cells promote wound healing by optimizing cellular functions via AKT and ERK signaling pathways." in: Stem cell research & therapy, Vol. 10, Issue 1, pp. 47, (2020) (PubMed).
: "Integrated Proteomic and Transcriptomic Analysis Reveals Long Noncoding RNA HOX Transcript Antisense Intergenic RNA (HOTAIR) Promotes Hepatocellular Carcinoma Cell Proliferation by Regulating Opioid ..." in: Molecular & cellular proteomics : MCP, Vol. 17, Issue 1, pp. 146-159, (2019) (PubMed).
: "DDX5 plays essential transcriptional and post-transcriptional roles in the maintenance and function of spermatogonia." in: Nature communications, Vol. 10, Issue 1, pp. 2278, (2019) (PubMed).
: "IGFBP6 is a novel nasopharyngeal carcinoma prognostic biomarker." in: Oncotarget, Vol. 7, Issue 42, pp. 68140-68150, (2018) (PubMed).
: "α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway." in: Oncogenesis, Vol. 6, Issue 5, pp. e343, (2018) (PubMed).
: "Regulation of Signaling Pathways Involved in the Anti-proliferative and Apoptosis-inducing Effects of M22 against Non-small Cell Lung Adenocarcinoma A549 Cells." in: Scientific reports, Vol. 8, Issue 1, pp. 992, (2018) (PubMed).
: "Upregulation of E‑cadherin expression mediated by a novel dsRNA suppresses the growth and metastasis of bladder cancer cells by inhibiting β-catenin/TCF target genes." in: International journal of oncology, Vol. 52, Issue 6, pp. 1815-1826, (2018) (PubMed).
: "The Toll-like receptor ligand, CpG oligodeoxynucleotides, regulate proliferation and osteogenic differentiation of osteoblast." in: Journal of orthopaedic surgery and research, Vol. 15, Issue 1, pp. 327, (2021) (PubMed).
: "ASIC1a Inhibitor mambalgin-2 Suppresses the Growth of Leukemia Cells by Cell Cycle Arrest." in: Acta naturae, Vol. 12, Issue 2, pp. 101-116, (2020) (PubMed).
: "Microvesicles from human adipose stem cells promote wound healing by optimizing cellular functions via AKT and ERK signaling pathways." in: Stem cell research & therapy, Vol. 10, Issue 1, pp. 47, (2020) (PubMed).
: "Integrated Proteomic and Transcriptomic Analysis Reveals Long Noncoding RNA HOX Transcript Antisense Intergenic RNA (HOTAIR) Promotes Hepatocellular Carcinoma Cell Proliferation by Regulating Opioid ..." in: Molecular & cellular proteomics : MCP, Vol. 17, Issue 1, pp. 146-159, (2019) (PubMed).
: "DDX5 plays essential transcriptional and post-transcriptional roles in the maintenance and function of spermatogonia." in: Nature communications, Vol. 10, Issue 1, pp. 2278, (2019) (PubMed).
: "IGFBP6 is a novel nasopharyngeal carcinoma prognostic biomarker." in: Oncotarget, Vol. 7, Issue 42, pp. 68140-68150, (2018) (PubMed).
: "α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway." in: Oncogenesis, Vol. 6, Issue 5, pp. e343, (2018) (PubMed).
: "Regulation of Signaling Pathways Involved in the Anti-proliferative and Apoptosis-inducing Effects of M22 against Non-small Cell Lung Adenocarcinoma A549 Cells." in: Scientific reports, Vol. 8, Issue 1, pp. 992, (2018) (PubMed).
: "Upregulation of E‑cadherin expression mediated by a novel dsRNA suppresses the growth and metastasis of bladder cancer cells by inhibiting β-catenin/TCF target genes." in: International journal of oncology, Vol. 52, Issue 6, pp. 1815-1826, (2018) (PubMed).
Aliases for Cyclin D1 抗体
cyclin D1 (CCND1) 抗体cyclin D1 (Ccnd1) 抗体
cyclin D1 (ccnd1) 抗体
cyclin D1 S homeolog (ccnd1.S) 抗体
cyclin D1 L homeolog (ccnd1.L) 抗体
AI327039 抗体
bcl-1 抗体
BCL1 抗体
bcl1 抗体
cb161 抗体
ccnd1 抗体
CCND1 抗体
ccnd1a 抗体
ccnd1b 抗体
cD1 抗体
CycD1 抗体
cycd1 抗体
Cyl-1 抗体
D11S287E 抗体
d11s287e 抗体
etID37810.7 抗体
fb52e01 抗体
fc45c08 抗体
fc83a12 抗体
id:ibd1198 抗体
PRAD1 抗体
prad1 抗体
U21B31 抗体
u21b31 抗体
wu:fb52e01 抗体
wu:fc45c08 抗体
wu:fc83a12 抗体
您还需要查找其他产品吗？
You are here:
